Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP808930.RAC_EeATiflTwM7zY7OGy3FrrLjErceg_QYpGDtJOJv88130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP808930.RAC_EeATiflTwM7zY7OGy3FrrLjErceg_QYpGDtJOJv88130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP808930.RAC_EeATiflTwM7zY7OGy3FrrLjErceg_QYpGDtJOJv88130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP808930.RAC_EeATiflTwM7zY7OGy3FrrLjErceg_QYpGDtJOJv88130_provenance.
- NP808930.RAC_EeATiflTwM7zY7OGy3FrrLjErceg_QYpGDtJOJv88130_assertion description "[Conversely, the PAR1 antagonist was beneficial to hMPV infection by decreasing weight loss and clinical signs and by significantly reducing pulmonary inflammation, pro-inflammatory cytokine levels (including IL-6, KC and MCP-1) and recruitment of immune cells to the lungs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP808930.RAC_EeATiflTwM7zY7OGy3FrrLjErceg_QYpGDtJOJv88130_provenance.
- NP808930.RAC_EeATiflTwM7zY7OGy3FrrLjErceg_QYpGDtJOJv88130_assertion evidence source_evidence_literature NP808930.RAC_EeATiflTwM7zY7OGy3FrrLjErceg_QYpGDtJOJv88130_provenance.
- NP808930.RAC_EeATiflTwM7zY7OGy3FrrLjErceg_QYpGDtJOJv88130_assertion SIO_000772 24015257 NP808930.RAC_EeATiflTwM7zY7OGy3FrrLjErceg_QYpGDtJOJv88130_provenance.
- NP808930.RAC_EeATiflTwM7zY7OGy3FrrLjErceg_QYpGDtJOJv88130_assertion wasDerivedFrom befree-20150227 NP808930.RAC_EeATiflTwM7zY7OGy3FrrLjErceg_QYpGDtJOJv88130_provenance.
- NP808930.RAC_EeATiflTwM7zY7OGy3FrrLjErceg_QYpGDtJOJv88130_assertion wasGeneratedBy ECO_0000203 NP808930.RAC_EeATiflTwM7zY7OGy3FrrLjErceg_QYpGDtJOJv88130_provenance.
- befree-20150227 importedOn "2015-02-27" NP808930.RAC_EeATiflTwM7zY7OGy3FrrLjErceg_QYpGDtJOJv88130_provenance.